Publications and Presentations
From Lab to Market: A Guide to Commercializing Life Science Innovation
Law Journal Press Treatises
|
To be published in 2011/2012
The Public Company Primer: A Practical Guide to Going Public, Raising Capital and Life as a Public Company
RR Donnelley
|
2011, 2010, 2009, 2007 and 2006 Editions
SEC Revises Policy on Confidential Submissions by Foreign Private Issuers
VC Experts
|
December 2011
Legal Path To Launch: Regulatory Approval, Device Funding, Pricing & Setting Up Your Business
Canadian Medical Device Market Access & Government Affairs
|
December 5, 2011
View from Wall Street - U.S. Investment Bankers
BioFinance, Toronto
|
June 1, 2011
Doing a Deal with Pharma
Bio Business
|
May/June 2011
From Israel to MaRS
MaRS Discovery District
|
April 12, 2011
Six Rules for Wooing Investors
Bio Business
|
March/April, 2011
Working with the Pharmaceutical Industry
Tech Transfer Summit North America
|
November 23, 2010
Financing Medical Device Companies
The Health Technology Exchange Conference
|
October 13, 2010
Pharma/Biotech Royalty Monetization
Licensing Executives Society Annual Conference
|
September 29, 2010
Biotech Licensing and Alliances
Global Business & Legal Seminars LLC
|
May 25, 2010
Über Tech Transfer
2010 Bio International, Chicago
|
May 6, 2010
Luncheon will Dealmakers - View from Wall Street
BioFinance 2010, Toronto
|
April 7, 2010
Dissecting a Billion Dollar Collaboration: BioMS Medical and Eli Lilly
Bio International, Atlanta
|
May 21, 2009
Transactions for Life Science Companies in Volatile Times
BioFinance, Toronto
|
April 29, 2009
Cross Border Financings
Lab-to-Market: Matching Israeli Innovation to Canadian Know-How
|
February 3, 2009
Anatomy of a Deal: BioMS Medical and Eli Lilly
BioFinance, Toronto
|
May 7, 2008
U.S. Venture Capital Panel
BioFinance, Toronto
|
April 24-25, 2007
China's New Foreign Investment Legislation Encourages Participation in Biotech Industry
The Lawyers Weekly
|
March 2, 2007
Data Protection PM(NOC)/Orange Book: A Cross-Border Perspective of Impact on Licensing Deals
CHLA, Toronto
|
December 12, 2006
Lessons for Energy Venture Investors Learned From the BioTech Experience
Energy Venture Fair VII, Santa Clara
|
November 9, 2006
Early Stage Life Science Financing: U.S. Financial Market Perspective
BioFinance Early Phase 2006, Toronto
|
November 1, 2006
Things that Go Sour in Licensing and Alliances: Issues You Wish You Had Considered
BioContact Quebec
|
October 5, 2006
Five Strategies for a Life Sciences Company
Law.com
|
September 2006
Law Firm Due Diligence for Life Sciences Companies
CHLA, Niagara-on-the-Lake
|
June 23, 2006
Non-traditional Partners for Biotechnology Companies
BioMedex 2006, Montreal
|
May 24, 2006
U.S. Venture Capital Managers
Moderator, BioFinance, Toronto
|
May 4, 2006
U.S. Financing Sources and Issues: How Small Companies Can Prepare
BioFinance Early Phase 2005, Toronto
|
November 16, 2005
Financing Perspective on Stem Cell Research
Stem Cells: Unlocking the Potential, Ontario Genomics Institute, Toronto
|
October 2005
Are Investment Banks Still in the IPO Game?
From Research to Revenue, Toronto Biotechnology Initiative
|
September 30, 2005
Canadian Biotech Companies: When and Where to Go Public
Biotechnology Focus, vol. 8, no. 9
|
September 1, 2005
Israeli Life Science: Entering the U.S. Market
BIO 2005, Philadelphia
|
June 21, 2005
Maximizing Returns on M&A Transactions for Life Sciences Companies: Structural and Legal Issues
Canadian Venture Capital Association 2005, Quebec City
|
June 2, 2005
Investment Banking: Extreme Makeover in Biotech
BioFinance 2005, Toronto
|
May 2005
Growing a Life Science Company
Bio Business
|
April 1, 2005
Internal Control over Financial Reporting for Canada and the United States
CFO Roundtable, KPMG and BIOTECanada Biopharma, Toronto
|
April 2005
U.S. Financing for Medical Device Companies
Panelist, Biomedex 2005, Montreal
|
March 2005
Stem Cell Research in Canada: Business Opportunities for U.S. Companies
The Journal of Biolaw & Business, vol. 8, no. 1
|
January 1, 2005
The eHealth Industry: General Business and Financing Issues
2004 Supplement, eHealth Business and Transaction Law
|
2004
Finding U.S. Venture Capital: How Small Companies Can Prepare
BioFinance Early Phase 2004, Toronto
|
November 10, 2004
An Insider's Guide to Going Public
Co-author, RR Donnelley
|
2001-2004 editions
Reality Check: D&O Insurance—Addressing Common Pitfalls
The Daily Deal
|
November 3, 2003
Going Public Post–Sarbanes-Oxley
Presentation to Canadian corporate attorneys, Toronto
|
2003
Alternative Funding Sources for Foreign Biotech Companies
New Zealand Delegates Reception, BIO 2003, Washington, D.C.
|
June 2003
Licensing for Life Science Companies
Private Equity Training Session, New York
|
March 2003
Highlights, Challenges and Impact of the Sarbanes-Oxley Act of 2002
Investor Protection Reforms and Cross-border Securities Regulation, Toronto
|
December 2002
Licensing for Life Science Companies
MPM Capital Educational Series, Boston
|
July 2002
Early-stage VC Investment: Alternative Structures
Israel–US VC Conference, New York
|
July 2002
Biotech Companies: The Future
Reception for Israeli Biotech Companies, BIO 2002, Toronto
|
June 2002
Doing Business Globally: Israeli Success Stories
BIO 2002, Toronto
|
June 2002
Israel Companies as a Paradigm for Other Companies
Moderator, BIO 2002, Toronto
|
June 2002
The Commitment Continues: An Update on Trends in the Biotech Venture Capital Industry
Bio Financing Conference 2002, Boston
|
May 2002
The Global Private Equity Market
Estate Administration Conference, New York
|
May 2002
The Commitment Continues: An Update on Trends in the Biotech Venture Capital Industry
Bio Financing Conference 2002, Boston
|
May 2002
Efficient and Cost-effective Access to Capital: What is the Future for Biotech Early Stage Companies
Bio Financing Conference 2001, San Diego
|
November 2001
Making the Match: Biotech Companies and Funding Sources
The Daily Deal
|
October 29, 2001
Positioning Your Genomic Company for Financing
Health Care Forum: Legal Developments in Genomics, Boston
|
October 2001
Emerging Industries and Their Valuation Trends: What is Driving Growth
Valuing New Economy Companies III Conference, New York
|
April 2001
Minority Shareholder Rights
Korean Chamber of Commerce
|
April 2001